Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients. - Wikidata - awgldk - TriplyDB

Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients.

Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients.

http://www.wikidata.org/entity/Q37268285

about

Effect of dexamethasone, insulin and EGF on the myogenic potential on human endometrial stem cell.Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial.Predisposing Factors for Hypoglycemia and Its Relation With Mortality in Critically Ill Patients Undergoing Insulin Therapy in an Intensive Care Unit.Effect of a Probiotic Preparation (VSL#3) on CardiovascularRisk Parameters in Critically-Ill Patients.The Effect of Omega-3 Fatty Acids on ARDS: A Randomized Double-Blind Study.In vivo and in vitro protective effects of omeprazole against neuropathic pain.Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial.

P2860

Q34146172-2396F33F-42E6-42E5-8582-4E48E0EF15F3 Q34715954-9F1001A0-D0F1-4645-A231-5D9DD9AB2DEB Q36809606-ED1A7338-E3BE-410A-B40F-5085C1C2CB2F Q37301733-4910DB67-34A1-4C24-A6D4-001151D072AC Q41826559-7A89CEEA-DF6F-4FF9-97BF-C0966091ADA4 Q41830886-96388673-E599-4EFA-9A9A-327901495A8A Q42867694-DF4C0A7C-0322-4D66-B817-54B851979E81

P2860

Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients.

http://www.wikidata.org/entity/Q37268285

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of Pantoprazole on Sys ...... es in Critically Ill Patients.

@en

Effects of Pantoprazole on Sys ...... es in Critically Ill Patients.

@nl

type

label

Effects of Pantoprazole on Sys ...... es in Critically Ill Patients.

@en

Effects of Pantoprazole on Sys ...... es in Critically Ill Patients.

@nl

prefLabel

Effects of Pantoprazole on Sys ...... es in Critically Ill Patients.

@en

Effects of Pantoprazole on Sys ...... es in Critically Ill Patients.

@nl

P1433

Q37268285-B5CC8F4C-D6C2-4A8F-A01F-93231FC35E21

P1476

Q37268285-A6891849-7EA0-4A13-91B8-734343BB83EA

P2093

Q37268285-1AD0DA41-24ED-4D9F-B8C7-BC9AC63FF9E6

Q37268285-52A5DDC1-FBFF-41FC-97C4-58D3C58A8246

Q37268285-58E142E5-07A9-4CCE-89BE-0D1177EF77AB

Q37268285-98697447-0FE4-41E2-A91F-3BAA02CC20D1

Q37268285-AB3C0AF9-3DBC-4005-82BC-275FC936D3D1

Q37268285-D255B591-E03D-4897-A501-939BADE67A5F

Q37268285-D5ABE80F-FFDF-4C1B-89FF-8015194FC85A

Q37268285-DEB4FEA6-2FA6-4A9F-B667-A789EE450B9E

P2860

Q37268285-02D6E630-FED5-431E-959E-AB8582D6EB33

Q37268285-0AF02D9A-0205-4379-81DD-1096B177C376

Q37268285-25EBF044-0BCA-4DBC-9D98-C4D1F0904DF6

Q37268285-2A4A4DE8-DA88-4FD4-AA4E-CBAD94B39925

Q37268285-3804FD32-894B-4FB2-B1C3-52183A8C9A24

Q37268285-3ACA0327-BBDC-46B0-B1CF-314A02C958B3

Q37268285-3B5DE8C4-4E10-47AB-8378-B43EED0AB16B

Q37268285-44510727-E4F5-476A-9D0A-EB30E2E491AB

Q37268285-56E31403-61AB-45F8-8E16-4774CFE0F692

Q37268285-62A276FC-1C3C-48A4-A33C-92996A34AF84

P304

Q37268285-0704F7F2-9E80-4AFE-B78C-057BE11C8E03

P31

Q37268285-890C0D23-E1D2-4B31-985F-31315228F978

P433

Q37268285-BD2052D8-965D-48FE-99F8-64EEC77188EE

P478

Q37268285-01686541-9A85-4F23-8BB3-AAF6F52F6555

P50

Q37268285-BC3EC5FB-A737-4219-9E42-B224D456D3CF

P577

Q37268285-8B7C68B0-7FB6-4268-868C-9E20687D547E

P698

Q37268285-5D3E9D1B-40B5-4F71-B4D2-6FF1B03BCB28

P921

Q37268285-00DFAB0A-C716-4503-8653-7932318086BD

P932

Q37268285-1FFCAEDC-55B3-4F67-AC8D-C0F74086DD71

P1433

Iranian Journal of Pharmaceutical Research

P1476

Effects of Pantoprazole on Sys ...... es in Critically Ill Patients.

@en

P2093

Arezoo Ahmadi

http://www.w3.org/2001/XMLSchema#string

Ata Mahmoodpoor

http://www.w3.org/2001/XMLSchema#string

Atabak Najafi

http://www.w3.org/2001/XMLSchema#string

Hamed Tabeefar

http://www.w3.org/2001/XMLSchema#string

Hooshyar Honarmand

http://www.w3.org/2001/XMLSchema#string

Mohammad Reza Javadi

http://www.w3.org/2001/XMLSchema#string

Mohammad Taghi Beigmohammadi

http://www.w3.org/2001/XMLSchema#string

Mojtaba Mojtahedzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestine

Stress-related mucosal disease in the intensive care unit: an update on prophylaxis.

GI complications in patients receiving mechanical ventilation.

Suppression of proinflammatory cytokine production in macrophages by lansoprazole.

Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.

Identification of enhanced cytokine generation following sepsis. Dream of magic bullet for mortality prediction and therapeutic evaluation.

Contemporary strategies for the prevention of stress-related mucosal bleeding.

A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors.

Therapeutic goals and treatment options for prevention of stress ulcer syndrome.

Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor-alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuc

P304

1051-1058

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Abdollahi

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24250536

http://www.w3.org/2001/XMLSchema#string

P921

P932

3813167

http://www.w3.org/2001/XMLSchema#string